FR314F - - Google Patents

Info

Publication number
FR314F
FR314F FR144905A FR144905A FR314F FR 314 F FR314 F FR 314F FR 144905 A FR144905 A FR 144905A FR 144905 A FR144905 A FR 144905A FR 314 F FR314 F FR 314F
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR144905A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR144905A priority Critical patent/FR314F/fr
Priority to BE729914D priority patent/BE729914A/xx
Priority to GB1380069A priority patent/GB1196229A/en
Priority to DE19691914456 priority patent/DE1914456A1/de
Application granted granted Critical
Publication of FR314F publication Critical patent/FR314F/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR144905A 1968-03-22 1968-03-22 Expired FR314F (enExample)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR144905A FR314F (enExample) 1968-03-22 1968-03-22
BE729914D BE729914A (enExample) 1968-03-22 1969-03-14
GB1380069A GB1196229A (en) 1968-03-22 1969-03-17 Improvements in or relating to a New Glyoxylic Acid Salt, process for its preparation and Therapeutical Composition containing same
DE19691914456 DE1914456A1 (de) 1968-03-22 1969-03-21 Papaveringlyoxylat,seine Herstellung und Verwendung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR144905A FR314F (enExample) 1968-03-22 1968-03-22

Publications (1)

Publication Number Publication Date
FR314F true FR314F (enExample) 1970-05-25

Family

ID=8647868

Family Applications (1)

Application Number Title Priority Date Filing Date
FR144905A Expired FR314F (enExample) 1968-03-22 1968-03-22

Country Status (4)

Country Link
BE (1) BE729914A (enExample)
DE (1) DE1914456A1 (enExample)
FR (1) FR314F (enExample)
GB (1) GB1196229A (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05013364A (es) 2003-06-17 2006-03-17 Arena Pharm Inc Procedimiento para preparar 3-benzazepinas.
US7704993B2 (en) 2003-06-17 2010-04-27 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
BRPI0515862A2 (pt) 2004-12-23 2011-10-11 Arena Pharm Inc uso de fentermina e agonista seletivo do receptor de 5ht-2c na preparação de composições, composições moduladoras do receptor de 5ht-2c e forma de dosagem unitária compreendendo as mesmas
JP5199997B2 (ja) 2006-04-03 2013-05-15 アリーナ ファーマシューティカルズ, インコーポレイテッド 8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンズアゼピンおよびこれに関連する中間体を調製するためのプロセス
JP5404414B2 (ja) 2006-12-05 2014-01-29 アリーナ ファーマシューティカルズ, インコーポレイテッド (r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンおよびその中間体を調製するための方法
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
WO2010148207A2 (en) 2009-06-18 2010-12-23 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ht2c 수용체 아고니스트의 제조 방법
SG188361A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Non-hygroscopic salts of 5-ht2c agonists
KR20130138770A (ko) 2010-09-01 2013-12-19 아레나 파마슈티칼스, 인크. 광학적으로 활성 산을 갖는 로르카세린의 염
US8999970B2 (en) 2010-09-01 2015-04-07 Arena Pharmaceuticals, Inc. Administration of an anti-obesity compound to individuals with renal impairment
EP3485878A1 (en) 2010-09-01 2019-05-22 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-ht2c agonists useful for weight management
CA2886875A1 (en) 2012-10-09 2014-04-17 Arena Pharmaceuticals, Inc. Method of weight management

Also Published As

Publication number Publication date
DE1914456A1 (de) 1971-06-16
GB1196229A (en) 1970-06-24
BE729914A (enExample) 1969-09-15

Similar Documents

Publication Publication Date Title
AU1946070A (enExample)
AU428130B2 (enExample)
AU5184069A (enExample)
AU6168869A (enExample)
AU416157B2 (enExample)
AU2952567A (enExample)
AU4811568A (enExample)
AU421558B1 (enExample)
AU4744468A (enExample)
AU3789668A (enExample)
AR203075Q (enExample)
AU2580267A (enExample)
AU3224368A (enExample)
BE709484A (enExample)
BE709496A (enExample)
BE642636A (enExample)
AU4464266A (enExample)
BE727034A (enExample)
BE709274A (enExample)
AU463027A (enExample)
BE709301A (enExample)
BE709095A (enExample)
AU3083868A (enExample)
AU4270368A (enExample)
BE581157A (enExample)